INOVIO PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
INOVIO PHARMACEUTICALS, INC. (INO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 202.41 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-10
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 202.41M shares, a 62.42% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 155.81M shares, a 58.85% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 124.62M shares, a 27.83% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 98.08M shares.
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 155.13M shares, a 57.14% increase from fiscal 2019.
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 98.72M shares, a 6.68% increase from fiscal 2018.
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 92.54M shares.
- INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 184.35M shares, a 35.05% increase from fiscal 2012.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | 202.41M shares 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | 155.13M shares 10-K · filed 2021-03-01 | |||
| 2020-06-30 | 155.81M shares 10-Q · filed 2020-08-10 | 140.22M shares 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | 124.62M shares 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | 98.72M shares 10-K · filed 2021-03-01 | |||
| 2019-06-30 | 98.08M shares 10-Q · filed 2020-08-10 | 97.80M shares 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | 97.49M shares 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | 92.54M shares 10-K · filed 2021-03-01 | |||
| 2018-03-31 | 90.45M shares 10-Q · filed 2019-05-09 | |||
| 2017-06-30 | 75.41M shares 10-Q · filed 2017-08-08 | 74.78M shares 10-Q · filed 2017-08-08 | ||
| 2016-06-30 | 72.96M shares 10-Q · filed 2017-08-08 | 72.59M shares 10-Q · filed 2017-08-08 | ||
| 2014-03-31 | 220.64M shares 10-Q · filed 2014-05-12 | 214.57M shares derived: average of 2 quarters · filed 2014-05-12 | 207.03M shares derived: average of 3 quarters · filed 2014-05-12 | 200.26M shares derived: average of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 208.51M shares 10-K · filed 2014-03-17 | 200.23M shares derived: average of 2 quarters · filed 2014-03-17 | 193.47M shares derived: average of 3 quarters · filed 2014-03-17 | 184.35M shares 10-K · filed 2014-03-17 |
| 2013-09-30 | 191.96M shares 10-K · filed 2014-03-17 | 185.96M shares derived: average of 2 quarters · filed 2014-03-17 | 176.18M shares 10-Q · filed 2013-11-12 | 167.19M shares derived: average of 4 quarters · filed 2014-05-12 |
| 2013-06-30 | 179.95M shares 10-K · filed 2014-03-17 | 168.19M shares 10-Q · filed 2013-08-09 | 158.94M shares derived: average of 3 quarters · filed 2014-05-12 | 153.05M shares derived: average of 4 quarters · filed 2014-05-12 |
| 2013-03-31 | 156.16M shares 10-Q · filed 2014-05-12 | 148.43M shares derived: average of 2 quarters · filed 2014-05-12 | 144.08M shares derived: average of 3 quarters · filed 2014-05-12 | 141.80M shares derived: average of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | 140.70M shares 10-K · filed 2014-03-17 | 138.05M shares derived: average of 2 quarters · filed 2014-03-17 | 137.02M shares derived: average of 3 quarters · filed 2014-03-17 | 136.51M shares 10-K · filed 2014-03-17 |
| 2012-09-30 | 135.39M shares 10-K · filed 2014-03-17 | 135.18M shares derived: average of 2 quarters · filed 2014-03-17 | 135.11M shares 10-Q · filed 2013-11-12 | 133.68M shares derived: average of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | 134.97M shares 10-K · filed 2014-03-17 | 134.97M shares 10-Q · filed 2013-08-09 | 133.11M shares derived: average of 3 quarters · filed 2014-03-17 | 131.64M shares derived: average of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | 134.97M shares 10-K · filed 2014-03-17 | 132.18M shares derived: average of 2 quarters · filed 2014-03-17 | 130.54M shares derived: average of 3 quarters · filed 2014-03-17 | 129.72M shares derived: average of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | 129.38M shares 10-K · filed 2013-03-18 | 128.32M shares derived: average of 2 quarters · filed 2013-03-18 | 127.97M shares derived: average of 3 quarters · filed 2013-03-18 | 126.24M shares 10-K · filed 2014-03-17 |
| 2011-09-30 | 127.26M shares 10-K · filed 2013-03-18 | 127.26M shares derived: average of 2 quarters · filed 2013-03-18 | 125.15M shares derived: average of 3 quarters · filed 2013-03-18 | |
| 2011-06-30 | 127.26M shares 10-K · filed 2013-03-18 | 124.09M shares derived: average of 2 quarters · filed 2013-03-18 | ||
| 2011-03-31 | 120.92M shares 10-K · filed 2013-03-18 | |||
| 2010-12-31 | 103.20M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |